Advertisement

Cancer Chemotherapy and Pharmacology

, Volume 84, Issue 1, pp 225–226 | Cite as

Stress resilience and survival among cancer patients: is there any absolute truth?

  • Raffaella MormileEmail author
Letter to the Editor
  • 28 Downloads

Chronic stress has been reported to have an impact on cancer progression [1]. Recently, stress resilience in late adolescence has been connected with survival among patients suffering from cancer [1]. Low compared with high stress resilience has been linked to increased mortality in cancer patients [1]. It has been observed that individual variations in stress resilience may influence survival among men with some types of cancer [1]. It has been indicated that there is a significant relationship between low stress resilience and mortality among men suffering from cancer, particularly oropharyngeal cancer, upper respiratory tract cancers, prostate cancer, and Hodgkin lymphoma [1]. To date, the potential influence of stress susceptibility on cancer progression still remains unknown [1]. Formerly, chronic stress has been described to trigger tumor growth and angiogenesis in a mouse model of ovarian cancer through activation of the tumor cell cyclic AMP(cAMP)–protein kinase A...

Notes

Compliance with ethical standards

Conflict of interest

The author declares no potential conflicts of interest.

References

  1. 1.
    Udumyan R, Montgomery S, Fang F, Valdimarsdottir U, Fall K (2018) Stress resilience in late adolescence and survival among cancer patients: a Swedish register-based cohort study. Cancer Epidemiol Biomarkers Prev.  https://doi.org/10.1158/1055-9965.epi-18-0451 Google Scholar
  2. 2.
    Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, Landen CN, Li Y, Felix E, Sanguino AM, Newman RA, Lloyd M, Gershenson DM, Kundra V, Lopez-Berestein G, Lutgendorf SK, Cole SW, Sood AK (2006) Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 12(8):939–944 (Epub 2006 Jul 23) CrossRefGoogle Scholar
  3. 3.
    Powell ND, Sloan EK, Bailey MT, Arevalo JM, Miller GE, Chen E, Kobor MS, Reader BF, Sheridan JF, Cole SW (2013) Social stress up-regulates inflammatory gene expression in the leukocyte transcriptome via β-adrenergic induction of myelopoiesis. Proc Natl Acad Sci USA. 110(41):16574–16579CrossRefGoogle Scholar
  4. 4.
    Lavine JA, Farnoodian M, Wang S, Darjatmoko SR, Wright LS, Gamm DM, Ip MS, Sorenson CM, Sheibani N (2017) β2-adrenergic receptor antagonism attenuates CNV through inhibition of VEGF and IL-6 expression. Invest Ophthalmol Vis Sci 58(1):299–308CrossRefGoogle Scholar
  5. 5.
    Schrepf A, Clevenger L, Christensen D, DeGeest K, Bender D, Ahmed A, Goodheart MJ, Dahmoush L, Penedo F, Lucci JA 3rd, Ganjei-Azar P, Mendez L, Markon K, Lubaroff DM, Thaker PH, Slavich GM, Sood AK, Lutgendorf SK (2013) Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability. Brain Behav Immun 30(Suppl):S126–S134CrossRefGoogle Scholar
  6. 6.
    Carpenter LL, Gawuga CE, Tyrka AR, Lee JK, Anderson GM, Price LH (2010) Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults. Neuropsychopharmacology. 35(13):2617–2623CrossRefGoogle Scholar
  7. 7.
    Erta M, Quintana A, Hidalgo J (2012) Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci. 8(9):1254–1266CrossRefGoogle Scholar
  8. 8.
    Levin LI, Breen EC, Birmann BM, Batista JL, Magpantay LI, Li Y, Ambinder RF, Mueller NE, Martínez-Maza O (2017) Elevated serum levels of sCD30 and IL6 and detectable IL10 precede classical Hodgkin lymphoma diagnosis. Cancer Epidemiol Biomarkers Prev 26(7):1114–1123CrossRefGoogle Scholar
  9. 9.
    Nguyen DP, Li J, Tewari AK (2014) Inflammation and prostate cancer: the role of interleukin 6 (IL-6). BJU Int. 113(6):986–992CrossRefGoogle Scholar
  10. 10.
    Nikakhlagh S, Ranjbari N, Khorami E, Saki N (2015) Association between serum levels of interleukin-6 and stage of laryngeal cancer. Iran J Otorhinolaryngol. 27(80):199–205Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Division of Pediatrics and NeonatologyMoscati HospitalAversaItaly

Personalised recommendations